Diagnostics

  • Transthyretin Amyloidosis (ATTRv): Advancing Early Diagnosis Through Genetic Testing

    Publications , Diagnostics November 12, 2025

    Transthyretin amyloidosis (ATTRv) is a progressive, life-threatening, and often underdiagnosed disease caused by the deposition of toxic transthyretin (TTR) amyloid fibrils in multiple tissues and… Read more

  • Award for Outstanding Achievements on Rare Diseases

    ARCHIMEDlife News , Diagnostics April 17, 2025
    We are very happy to share that our CEO, Dr. David C. Kasper, has been selected as the winner of the Award for Outstanding Achievements in… Read more
  • WORLDSymposium 2025 Poster Presentations – Updates on important diagnostic services

    ARCHIMEDlife News , Diagnostics February 21, 2025
    The WORLDSymposium for Lysosomal Storage Disorders convened in San Diego, CA, USA earlier this month. This important meeting brings together industry, physicians, advocate groups, and… Read more
  • Importance to include differential diagnostics for acid sphingomyelinase deficiency (ASMD) in patients suspected to have to Gaucher disease

    Publications , Diagnostics June 1, 2023

    Acid sphingomyelinase deficiency (ASMD), commonly called Niemann-Pick A/B disease, is an autosomal recessively inherited lysosomal storage disorder resulting from a deficiency in acid sphingomyelinase (ASM)… Read more

  • Molecular basis of mucopolysaccharidosis IVA (Morquio A syndrome): A review and classification of GALNS gene variants and reporting of 68 novel variants

    Publications , Diagnostics August 13, 2021

    Mucopolysaccharidosis IVA (MPS IVA, Morquio A syndrome) is a rare autosomal recessive lysosomal storage disorder caused by mutations in the N-acetylgalactosamine-6-sulfatase (GALNS) gene. We collected,… Read more

  • Lyso-GL-3: An important Fabry biomarker associated with adverse clinical outcomes

    Publications , Diagnostics April 1, 2021

    Biomarkers in Rare Diseases play a dual and significant role in supporting improved clinical outcomes. In Fabry Disease (FD), the glycosphingolipid globotriaosylceramide (Gb3/GL-3) and its… Read more